BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25427043)

  • 1. The application of immunohistochemical biomarkers in urologic surgical pathology.
    Wilkerson ML; Lin F; Liu H; Cheng L
    Arch Pathol Lab Med; 2014 Dec; 138(12):1643-65. PubMed ID: 25427043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical Applications of Immunohistochemistry in the Diagnosis of Genitourinary Tumors.
    Xiao X; Hu R; Deng FM; Shen SS; Yang XJ; Wu CL
    Arch Pathol Lab Med; 2017 Sep; 141(9):1181-1194. PubMed ID: 28608721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Application and Pitfalls of Immunohistochemical Markers in Challenging Diagnosis of Genitourinary Pathology.
    Li J; Wilkerson ML; Deng FM; Liu H
    Arch Pathol Lab Med; 2024 Jan; 148(1):13-32. PubMed ID: 37074862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selected common diagnostic problems in urologic pathology: perspectives from a large consult service in genitourinary pathology.
    Brimo F; Epstein JI
    Arch Pathol Lab Med; 2012 Apr; 136(4):360-71. PubMed ID: 22458899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Best practices recommendations in the application of immunohistochemistry in the bladder lesions: report from the International Society of Urologic Pathology consensus conference.
    Amin MB; Trpkov K; Lopez-Beltran A; Grignon D;
    Am J Surg Pathol; 2014 Aug; 38(8):e20-34. PubMed ID: 25029121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Best practices recommendations in the application of immunohistochemistry in the kidney tumors: report from the International Society of Urologic Pathology consensus conference.
    Reuter VE; Argani P; Zhou M; Delahunt B;
    Am J Surg Pathol; 2014 Aug; 38(8):e35-49. PubMed ID: 25025368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns in immunohistochemical usage in extended core prostate biopsies: comparisons among genitourinary pathologists and nongenitourinary pathologists.
    Plourde A; Gross A; Jiang Z; Owens CL
    Arch Pathol Lab Med; 2013 Nov; 137(11):1630-4. PubMed ID: 24168501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphology and therapeutic strategies for neuroendocrine tumors of the genitourinary tract.
    Helpap B
    Cancer; 2002 Oct; 95(7):1415-20. PubMed ID: 12237909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on the application of newly described immunohistochemical markers in soft tissue pathology.
    Lin G; Doyle LA
    Arch Pathol Lab Med; 2015 Jan; 139(1):106-21. PubMed ID: 25549147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry.
    Hsu FD; Nielsen TO; Alkushi A; Dupuis B; Huntsman D; Liu CL; van de Rijn M; Gilks CB
    Mod Pathol; 2002 Dec; 15(12):1374-80. PubMed ID: 12481020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of immunohistochemistry in breast pathology: a review and update.
    Liu H
    Arch Pathol Lab Med; 2014 Dec; 138(12):1629-42. PubMed ID: 25427042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic role of immunohistochemistry in the evaluation of breast pathology specimens.
    Zhao L; Yang X; Khan A; Kandil D
    Arch Pathol Lab Med; 2014 Jan; 138(1):16-24. PubMed ID: 24377808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical staining characteristics of nephrogenic adenoma using the PIN-4 cocktail (p63, AMACR, and CK903) and GATA-3.
    McDaniel AS; Chinnaiyan AM; Siddiqui J; McKenney JK; Mehra R
    Am J Surg Pathol; 2014 Dec; 38(12):1664-71. PubMed ID: 24921643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference.
    Epstein JI; Egevad L; Humphrey PA; Montironi R;
    Am J Surg Pathol; 2014 Aug; 38(8):e6-e19. PubMed ID: 25029122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of p63 immunohistochemical stain in differentiating urothelial carcinomas from adenocarcinomas of prostate.
    Ud Din N; Qureshi A; Mansoor S
    Indian J Pathol Microbiol; 2011; 54(1):59-62. PubMed ID: 21393879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of frozen section in genitourinary pathology.
    Shen SS; Truong LD; Ro JY; Ayala AG
    Pathology; 2012 Aug; 44(5):427-33. PubMed ID: 22772345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updates in Benign Lesions of the Genitourinary Tract.
    Arias-Stella JA; Williamson SR
    Surg Pathol Clin; 2015 Dec; 8(4):755-87. PubMed ID: 26612226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of immunohistochemistry in the differential diagnosis of gynecologic disorders.
    Kaspar HG; Crum CP
    Arch Pathol Lab Med; 2015 Jan; 139(1):39-54. PubMed ID: 25549143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second opinion pathology in tertiary care of patients with urologic malignancies.
    Wayment RO; Bourne A; Kay P; Tarter TH
    Urol Oncol; 2011; 29(2):194-8. PubMed ID: 19523859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical Immunohistochemistry in Neoplastic Pathology of the Gastrointestinal Tract, Liver, Biliary Tract, and Pancreas.
    Wang HL; Kim CJ; Koo J; Zhou W; Choi EK; Arcega R; Chen ZE; Wang H; Zhang L; Lin F
    Arch Pathol Lab Med; 2017 Sep; 141(9):1155-1180. PubMed ID: 28854347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.